Form 8-K - Current report:
SEC Accession No. 0000950170-25-112253
Filing Date
2025-08-29
Accepted
2025-08-29 16:58:02
Documents
13
Period of Report
2025-08-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srzn-20250829.htm   iXBRL 8-K 58870
2 EX-1.1 srzn-ex1_1.htm EX-1.1 401057
3 EX-5.1 srzn-ex5_1.htm EX-5.1 25049
4 GRAPHIC img200110477_0.jpg GRAPHIC 90263
  Complete submission text file 0000950170-25-112253.txt   815582

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT srzn-20250829.xsd EX-101.SCH 46365
16 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20250829_htm.xml XML 6600
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39635 | Film No.: 251281742
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)